Blood vessels are not static pipes. During development, and indeed whenever tissues grow or repair themselves, vascular networks must be extensively remodeled: new sprouts extend into avascular territory, redundant branches regress, and existing vessels adapt their caliber and shape to match the demands of blood flow. In the central nervous system, this orchestration is guided in part by Wnt signaling, a family of pathways with two major branches. The canonical Wnt/β-catenin branch is well established as a regulator of endothelial specialization and of the blood–brain barrier, the selective fortress that shields neural tissue from the bloodstream. The non-canonical Wnt/Planar Cell Polarity (PCP) branch, by contrast, is known to govern vascular remodeling and the ability of endothelial cells to sense and adapt to the mechanical forces of flowing blood. What has remained stubbornly unclear is how the PCP pathway—activated at the cell surface—translates its instructions into the internal polarity machinery that tells a cell which way is forward.

The new study, led by Cécile Duplàa and Thierry Couffinhal of Inserm unit UMR1034 at the University of Bordeaux, with contributions from Alexandre Dubrac at the Sainte-Justine Research Center and Université de Montréal, answers that question by zeroing in on MCC, short for Mutated in Colorectal Cancer. MCC is a PDZ-domain protein, a class of scaffold molecules that physically assemble signaling complexes at specific cellular locations. It had previously been implicated in cell migration in epithelial cells and identified as an effector of non-canonical Wnt signaling during convergence and extension movements in zebrafish embryos—developmental processes that depend intimately on planar cell polarity. The Bordeaux team, building on their laboratory’s long-standing interest in vascular morphogenesis, hypothesized that MCC might perform an analogous role inside endothelial cells.

The researchers’ mechanistic work centered on a striking molecular partnership. Using proximity-dependent biotinylation (BioID), a technique that maps proteins sitting close to a protein of interest within living cells, combined with mass spectrometry proteomics, they found that MCC interacts with CEP131, a component of centriolar satellites. Centriolar satellites are electron-dense granules that cluster around the centrosome—the cell’s principal microtubule-organizing center—and help regulate centrosome function, protein turnover and cilia biology. The team’s proteomics data, deposited in the ProteomeXchange Consortium, show that MCC does not merely associate with CEP131; it actively promotes the satellite protein’s degradation, engaging both the proteasome, the cell’s cytosolic protein-shredding machinery, and autophagy, the lysosomal degradation system often used for bulk recycling of cellular components. In other words, MCC functions as a quality-control switch for the structures surrounding the centrosome.

Why would this matter for polarity? The answer lies in the geometry of a migrating endothelial cell. To move directionally, a cell must establish a front–rear axis: the microtubule cytoskeleton and the microtubule-organizing center must be positioned and oriented toward the leading edge, while the Golgi apparatus and nucleus reposition accordingly. Previous work from several groups, including studies showing that excess centrosomes scatter and derail endothelial migration, had established that centrosome-associated organization is a linchpin of directional movement. By keeping centriolar satellite material in check through regulated turnover, MCC appears to preserve the clean, polarized centrosomal architecture that directional migration demands. When the researchers depleted MCC from endothelial cells, this organization fell apart—and with it, the cells’ ability to polarize front-to-back.

One of the most intriguing findings of the study is what did not fall apart. When the team subjected MCC-depleted endothelial cells to flow, mimicking the shear stress that blood exerts on vessel walls in vivo, the cells still elongated and aligned their cytoskeletons with the direction of flow—indeed, this flow-induced elongation was preserved and even enhanced. This dissociation is biologically revealing. It demonstrates that two processes often lumped together as “endothelial alignment” are mechanistically separable: the passive morphological response to fluid shear, in which cells stretch along the flow axis, can proceed without MCC, while the active, directional front–rear polarization required for guided migration depends on it. For vascular biologists, this functional split offers a new framework for dissecting how vessels respond to hemodynamic forces.

The in vivo evidence came from the postnatal mouse retina, a classic and visually tractable model of angiogenesis in which a vascular plexus expands radially across the retinal surface during the first weeks of life, driven by proliferating “tip” cells at the angiogenic front. When the researchers deleted the Mcc gene specifically in endothelial cells of newborn mice, the retinal vasculature failed to remodel properly. Vessel density was abnormal, endothelial proliferation dropped, and—critically—the front–rear polarity of endothelial cells at the angiogenic front was disrupted. Tip cells, which must polarize and migrate persistently to lead the vascular sprout, lost their organizational bearings.

To rule out the possibility that these polarity defects were merely secondary consequences of a grossly malformed vasculature, the team employed an elegant pharmacological intervention. Captopril, an angiotensin-converting enzyme inhibitor long used as a blood pressure drug, is known to normalize vascular density and promote vessel regression in the remodeling retina. When the researchers treated the MCC-deficient mice with captopril, vascular density normalized and pruning proceeded—but endothelial polarity remained broken. This result is pivotal: it indicates that MCC’s role is cell-intrinsic. The protein is not simply required to generate a vascular environment in which polarity is possible; it is required within each endothelial cell to construct the polarity machinery itself.

The study also situates MCC within a broader signaling hierarchy. Prior work by the Bordeaux group and collaborators had identified the E3 ubiquitin ligase PDZRN3 as a Wnt/PCP pathway component required for vascular morphogenesis, and proteomic analyses had placed PDZRN3 downstream of Wnt5a–Ror signaling, a prototypical non-canonical Wnt cascade. The new findings extend this wiring: MCC now emerges as a downstream effector that converts PCP pathway activity into centrosome-associated proteostasis—the controlled degradation of satellite components—thereby closing the gap between a signal received at the membrane and a polarized cytoskeleton inside the cell.

Beyond developmental biology, the work carries implications for human disease. MCC was originally named for its frequent mutation in colorectal tumors, and it has since been characterized as a putative tumor suppressor that represses β-catenin-dependent transcription. Its newly described role in endothelial biology suggests that alterations in MCC could contribute to vascular pathologies as well. Aberrant angiogenesis and defective vascular remodeling underlie a wide range of conditions, from diabetic retinopathy—where neurovascular crosstalk fails and vessels in the retina deteriorate—to ischemic disease, where therapeutic revascularization is limited by the vessels’ inability to remodel productively. Cerebral small vessel disease, another area of active investigation by members of the consortium, may also intersect with pathways controlling endothelial polarity and mechanosensing. If the MCC–CEP131 axis proves druggable, it could offer a handle for promoting or restraining vascular remodeling in clinical contexts.

The technical breadth of the study is itself noteworthy. The team combined live-cell polarity assays and automated image analysis, single-cell RNA sequencing of mouse retina—data publicly available through the Gene Expression Omnibus under accession GSE175895—and quantitative proteomics to characterize the MCC interactome. Such multi-omics integration is increasingly the norm in vascular biology, where the behavior of a single endothelial cell must be understood simultaneously at the level of gene expression, protein interaction networks and subcellular architecture.

For the field, the study fills a genuine conceptual hole. The Wnt/PCP pathway has been implicated in angiogenesis for nearly two decades, with components such as Celsr1, DAAM1 and Kif26b variously shown to regulate endothelial junctions, proliferation and polarity. Yet the route from pathway activation at the plasma membrane to the microtubule-organizing center has remained speculative. By identifying MCC as the bridge—and by showing that the bridge is built from regulated protein degradation at the centrosome—the Bordeaux-led consortium has supplied both the missing connection and a mechanistic explanation for why it matters. As vascular biologists now probe how this axis operates in pathological angiogenesis and in the mature vasculature of the adult brain, MCC may shed its reputation as merely a cancer gene and take on a new identity: a master organizer of the cell’s sense of direction.

Ion channels like PIEZO2 have long fascinated scientists due to their exquisite sensitivity to mechanical forces. Embedded in the membranes of various cell types, PIEZO2 channels convert physical stimuli, such as pressure or stretch, into biological signals. These channels underlie our ability to perceive gentle breezes and even the faintest touches on the skin. However, Dr. Hammes and her team have demonstrated that PIEZO2’s functional repertoire extends into the realm of cardiovascular morphology, particularly within the developing heart’s vascular system.

Utilizing advanced mouse models genetically engineered to lack or overexpress PIEZO2 in endothelial cells, the research team meticulously charted the consequences of altered PIEZO2 activity on coronary artery development. Their findings were striking: in the absence of PIEZO2, coronary vessels often failed to mature properly, resulting in abnormally narrow or misbranched arteries. This vascular malformation compromised oxygen delivery to the heart muscle, instigating compensatory hypertrophy – a thickening of cardiac tissue primarily observable in the left ventricle. Conversely, mice harboring a hyperactive PIEZO2 variant displayed parallel defects, illuminating the finely tuned balance required for normal cardiovascular patterning.

The clinical significance of these results is underscored by the connection between PIEZO2 mutations and rare human conditions, including Marden-Walker syndrome—a genetic disorder associated with aberrant PIEZO2 function. The team’s findings suggest that mechanotransduction via PIEZO2 is indispensable for orchestrating the biomechanical signals that guide coronary vessel morphogenesis, implicating faulty PIEZO2 activity in congenital cardiovascular abnormalities. Furthermore, genome-wide association studies in humans have linked PIEZO2 variants to prevalent cardiovascular diseases such as heart failure, hypertension, and aneurysm formation, reinforcing the broader impact of this mechanosensitive channel beyond embryonic development.

Technically, the researchers employed cutting-edge tissue clearing methods combined with light sheet microscopy to visualize coronary artery formation in unprecedented detail. By staining developing vessels with specific antibodies targeting PIEZO2-expressing endothelial cells, they captured high-resolution three-dimensional images demonstrating the spatial distribution and branching patterns of coronary arteries throughout embryonic stages. This approach facilitated an in-depth analysis of how altered ion channel signaling perturbs vascular architecture, bringing to light mechanisms that were previously invisible to conventional histological techniques.

A particularly intriguing aspect of PIEZO2 revealed by the study is its temporal expression pattern. The ion channel is predominantly active during embryogenesis within the endothelial cells of coronary arteries, orchestrating vascular formation before becoming largely silent after birth. However, emerging evidence suggests that PIEZO2 may be reactivated in adult hearts under pathological conditions, such as ischemic injury or coronary artery disease. This re-expression holds exciting therapeutic potential for promoting vascular regeneration and repair, positioning PIEZO2 as a candidate target for novel cardiovascular treatments.

Building on these preclinical insights, Dr. Hammes and colleagues are now extending their work to human models. Collaborations with the Helmholtz Institute for Translational AngioCardioScience and the Max Delbrück Center’s Pluripotent Stem Cell Technology Platform enable the use of human endothelial cells derived from pluripotent stem cells. This platform allows precise manipulation and observation of PIEZO2 expression and activity in human vascular cells, potentially bridging the translational gap between murine findings and clinical applications.

This translational approach is poised to catalyze breakthroughs in diagnostic precision. By enhancing our understanding of the genetic and molecular bases of congenital heart defects via PIEZO2 pathways, early identification of at-risk individuals could become feasible. Moreover, targeting PIEZO2 function pharmacologically could provide a preventative strategy against the progression or onset of cardiovascular diseases rooted in vascular developmental anomalies.

The research also prompts a reevaluation of the role of mechanosensation in cardiovascular biology. Traditionally associated with sensory neurons and touch perception, channels like PIEZO2 are now recognized as pivotal molecular transducers integrating mechanical forces during organogenesis. These forces guide cellular behavior, vascular remodeling, and tissue homeostasis in complex and dynamic ways, underscoring the interdisciplinary nature of modern cardiovascular research.

Crucially, the study spotlights the Max Delbrück Center’s unique collaborative environment, where multidisciplinary teams converge to tackle the intricacies of disease mechanisms. Contributions from labs specializing in molecular signaling, endothelial biology, and cardiac physiology collectively facilitated a comprehensive elucidation of PIEZO2’s role. This synergy exemplifies how integrating diverse expertise accelerates discovery and fosters innovation that can directly impact patient care.

Beyond the immediate cardiovascular implications, these findings may also influence related fields such as developmental biology, regenerative medicine, and genetic disease research. Understanding how mechanical forces are sensed at the molecular level to sculpt organ systems could inform strategies to engineer tissues or modulate cell behavior in various contexts, ultimately enhancing regenerative therapies.

In conclusion, the unveiling of PIEZO2 as a mechanosensitive ion channel essential to coronary artery development marks a paradigm shift in cardiovascular biology. This pioneering research by Dr. Hammes and her team not only deepens our comprehension of the molecular mechanisms governing heart formation but also opens new frontiers for diagnostic and therapeutic innovation aimed at combating congenital and acquired heart diseases. As investigations proceed into human models and adult cardiac pathology, PIEZO2 may emerge as a fate-shaping conduit between biomechanics and medicine.

Subject of Research: Animals

Article Title: Mechanosensitive PIEZO2 channels shape coronary artery development

News Publication Date: 27-Jun-2025

Web References:

• Hammes lab: https://www.mdc-berlin.de/hammes
• Lewin lab: https://www.mdc-berlin.de/lewin
• Gerhardt lab: https://www.mdc-berlin.de/gerhardt
• Hübner lab: https://www.mdc-berlin.de/huebner
• Helmholtz Institute for Translational AngioCardioScience: https://www.mdc-berlin.de/hi-tac
• Pluripotent Stem Cell Technology Platform: https://www.mdc-berlin.de/pluripotent-stem-cells

References:
DOI: http://dx.doi.org/10.1038/s44161-025-00677-3

Image Credits:
Mireia Pampols-Perez, Max Delbrück Center

Keywords:
PIEZO2, coronary artery development, mechanosensitive ion channels, congenital heart defects, endothelial cells, mechanotransduction, cardiac hypertrophy, vascular morphogenesis, Pluripotent Stem Cells, cardiovascular regeneration